BioAdvance

Summary

BioAdvance appeared to be the VC, which was created in 2003. The company was established in North America in United States. The leading representative office of defined VC is situated in the Philadelphia.

Besides them, we counted 5 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the BioAdvance, startups are often financed by Ben Franklin Technology Partners of Southeastern Pennsylvania, Dorm Room Fund, Robin Hood Ventures. The meaningful sponsors for the fund in investment in the same round are Ben Franklin Technology Partners of Southeastern Pennsylvania, Safeguard Scientifics, iSeed Ventures. In the next rounds fund is usually obtained by Ben Franklin Technology Partners of Southeastern Pennsylvania, Safeguard Scientifics, Robin Hood Ventures.

Comparing to the other companies, this BioAdvance performs on 21 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2010. Speaking about the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 7-12 investment rounds annually. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2010. Despite it in 2019 the fund had an activity.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Advaxis, Wellsheet, Bainbridge Health Among the most popular fund investment industries, there are Health Diagnostics, Pharmaceutical. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.